Objective
To investigate the value of the pre-operative amide proton transfer-weighted (APTw) MRI to assess the prognostic factors in rectal adenocarcinoma (RA).
Methods
This prospective study ran from January 2022 to September 2023 and consecutively enrolled participants with RA who underwent pre-operative MRI and radical surgery. The APTw signal intensity (SI) values of RA with various tumor (T), node (N) stages, perineural invasion (PNI), and tumor grade were compared by Mann–Whitney U-test or t-test. The receiver operating characteristic curve was used to evaluate the diagnostic performance of the APTw SI values.
Results
A total of 51 participants were enrolled (mean age, 58 years ± 10 [standard deviation], 26 men). There were 24 in the T1–T2 stage and 9 with positive PNI. The APTw SI max, 99th, and 95th values were significantly higher in T3–T4 stage tumor than in T1-T2; the median (interquartile range) (M (IQR)) was (4.0% (3.6–4.9%) vs 3.4% (2.9– 4.3%), p = 0.017), (3.7% (3.2–4.1%) vs 3.2% (2.8–3.8%), p = 0.013), and (3.3% (2.8–3.8%) vs 2.9% (2.3–3.5%), p = 0.033), respectively. These indicators also differed significantly between the PNI groups, with the M (IQR) (4.5% (3.6–5.7%) vs 3.7% (3.2–4.2%), p = 0.017), (4.1% (3.4–4.8%) vs 3.3% (3.0–3.9%), p = 0.022), and (3.7% (2.7–4.2%) vs 2.9% (2.6–3.5%), p = 0.045), respectively.
Conclusion
Pre-operative APTw MRI has potential value in the assessment of T-staging and PNI determination in RA.
Clinical relevance statement
Pre-operative amide proton transfer-weighted MRI provides a quantitative method for noninvasive assessment of T-staging and PNI in RA aiding in precision treatment planning.
Key Points
-
The efficacy of APTw MRI in RA needs further investigation.
-
T3–T4 stage and PNI positive APTw signal intensities were higher than T1–T2 and non-PNI, respectively.
-
APTw MRI provides a quantitative method for assessment of T staging and PNI in RA.
